106 related articles for article (PubMed ID: 15016479)
1. Altered nitric oxide production in mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin or methamphetamine.
Halász AS; Pálfi M; Tábi T; Magyar K; Szöko E
Neurochem Int; 2004 Jun; 44(8):641-6. PubMed ID: 15016479
[TBL] [Abstract][Full Text] [Related]
2. [Change of the nitric oxide synthase activity after administration of neurotoxic compounds in mice].
Halász AS; Pálfi M; Tábi T; Magyar K; Szöko E
Acta Pharm Hung; 2006; 76(1):33-6. PubMed ID: 17094674
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Itzhak Y; Martin JL; Ali SF
Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
[TBL] [Abstract][Full Text] [Related]
4. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Darvesh AS; Yamamoto BK; Gudelsky GA
J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
Anderson KL; Itzhak Y
Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
9. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
10. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
[TBL] [Abstract][Full Text] [Related]
11. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice.
Chalimoniuk M; Langfort J
Neurochem Int; 2007 May; 50(6):821-33. PubMed ID: 17379358
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice.
Selley ML
Brain Res; 2005 Mar; 1037(1-2):1-6. PubMed ID: 15777746
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.
Chalimoniuk M; Langfort J; Lukacova N; Marsala J
Biochem Biophys Res Commun; 2004 Nov; 324(1):118-26. PubMed ID: 15464991
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation.
Flora G; Lee YW; Nath A; Maragos W; Hennig B; Toborek M
Neuromolecular Med; 2002; 2(1):71-85. PubMed ID: 12230306
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
Bowyer JF; Robinson B; Ali S; Schmued LC
Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and reactive oxygen species in Parkinson's disease.
Tieu K; Ischiropoulos H; Przedborski S
IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
[TBL] [Abstract][Full Text] [Related]
17. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
Itzhak Y; Anderson KL; Ali SF
Ann N Y Acad Sci; 2004 Oct; 1025():119-28. PubMed ID: 15542708
[TBL] [Abstract][Full Text] [Related]
18. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury.
Bayir H; Kagan VE; Clark RS; Janesko-Feldman K; Rafikov R; Huang Z; Zhang X; Vagni V; Billiar TR; Kochanek PM
J Neurochem; 2007 Apr; 101(1):168-81. PubMed ID: 17394464
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite.
Brown JM; Quinton MS; Yamamoto BK
J Neurochem; 2005 Oct; 95(2):429-36. PubMed ID: 16086684
[TBL] [Abstract][Full Text] [Related]
20. [Effect of methamphetamine on the microglial cells and activity of nitric oxide synthases in rat striatum].
Li YH; Wang HJ; Qiao DF
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1789-91. PubMed ID: 18971173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
